Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
4(1H)-quinolones with liver stage activity against Plasmodium berghei
ArticleAbstract: With the exception of primaquine, tafenoquine, and atovaquone, there are very few antimalarials thatPalabras claves:Autores:Cross R.M., Fabián E. Sáenz, Kyle D.E., Lacrue A.N., Manetsch R., Monastyrskyi A., Mutka T.S., Stein S., Udenze K.O.Fuentes:googlescopus4-(1H)-quinolones and 1,2,3,4-tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni
ArticleAbstract: Malaria kills approximately 1 million people a year, mainly in sub-Saharan Africa. Essential steps iPalabras claves:Autores:Cross R.M., Fabián E. Sáenz, Kyle D.E., Lacrue A.N., Maignan J.R., Manetsch R., Udenze K.O.Fuentes:googlescopusQuinolone-3-diarylethers: A new class of antimalarial drug
ArticleAbstract: The goal for developing new antimalarial drugs is to find a molecule that can target multiple stagesPalabras claves:Autores:Angulo-Barturen I., Avery V.M., Bathurst I., Burrows J.N., Charman S.A., Cross R.M., Delves M.J., Duffy S., Fabián E. Sáenz, Ferrer S., Forquer I.P., Gamo F.J., Guy R.K., Herreros E., Jiménez-Díaz M.B., Kelly J.X., Kocken C.H.M., Kyle D.E., Lacrue A.N., Li Y., Manetsch R., Marfurt J., Mather M.W., Morrisey J.M., Mutka T.S., Nilsen A., Noviyanti R., Price R.N., Riscoe M.K., Ryan E., Sanz L.M., Sebayang B.F., Shackleford D.M., Siegl P., Sinden R.E., Steuten J., Vaidya A.B., White K.L., Winter R.W., Wirjanata G., Zeeman A.M.Fuentes:googlescopus